Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Stéphanie Cartalat"'
Autor:
François Ducray, Carole Ramirez, Marie Robert, Maxime Fontanilles, Charlotte Bronnimann, Olivier Chinot, Florian Estrade, Xavier Durando, Stéphanie Cartalat, Jeremy Bastid, Hugues Bienayme, Caroline Lemarchand
Publikováno v:
Pharmaceutics, Vol 15, Iss 12, p 2664 (2023)
Background: Temozolomide (TMZ) oral suspension (Ped-TMZ, KIZFIZO®) is being developed for the treatment of relapsed or refractory neuroblastoma, a rare cancer affecting infants and young children. The study assessed the safety and the bioequivalence
Externí odkaz:
https://doaj.org/article/29256ebc25c84872bd21f0f213c1dcc0
Autor:
François Ducray, Emmanuel Grenier, Jérôme Honnorat, Jean-Yves Delattre, Stéphanie Cartalat-Carel, Johan Pallud, Linda Dainese, Dimitri Psimaras, Ahmed Idbaih, Branka Čajavec-Bernard, Michel Tod, Vincent Calvez, Damien Ricard, Mathieu Peyre, Gentian Kaloshi, Benjamin Ribba
Purpose: To develop a tumor growth inhibition model for adult diffuse low-grade gliomas (LGG) able to describe tumor size evolution in patients treated with chemotherapy or radiotherapy.Experimental Design: Using longitudinal mean tumor diameter (MTD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c162dec91a34576176ccdf123d431623
https://doi.org/10.1158/1078-0432.c.6520731
https://doi.org/10.1158/1078-0432.c.6520731
Autor:
François Ducray, Emmanuel Grenier, Jérôme Honnorat, Jean-Yves Delattre, Stéphanie Cartalat-Carel, Johan Pallud, Linda Dainese, Dimitri Psimaras, Ahmed Idbaih, Branka Čajavec-Bernard, Michel Tod, Vincent Calvez, Damien Ricard, Mathieu Peyre, Gentian Kaloshi, Benjamin Ribba
PDF file, 258K, Figure S 1: Stepwise procedure applied to build the model structure (left panel); non-specific and specific evaluation criteria for model selection (right panel). Figure S 2: Results of the sensitivity analysis for the model on the 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3572634498da7877c7236e038713cd4b
https://doi.org/10.1158/1078-0432.22446384
https://doi.org/10.1158/1078-0432.22446384
Autor:
Freyer, Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, Sara Calattini, Stéphanie Cartalat, Marion Chauvenet, Marc Colombel, Stéphane Dalle, Tristan Dagonneau, Marie Darrason, Gilles Devouassoux, Michaël Duruisseaux, Marielle Guillet, Olivier Glehen, Pierre Philouze, François Tronc, Thomas Walter, Benoît You, Gilles
Publikováno v:
Cancers; Volume 14; Issue 1; Pages: 29
This article presents the protective measures put in place at the “Institut de Cancérologie des Hospices de Lyon” (IC-HCL) during the first wave of the COVID-19 pandemic in France (spring 2020) and how they impacted IC-HCL clinical activity. Spr
Autor:
Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, Sara Calattini, Stéphanie Cartalat, Marion Chauvenet, Marc Colombel, Stéphane Dalle, Tristan Dagonneau, Marie Darrason, Gilles Devouassoux, Michaël Duruisseaux, Marielle Guillet, Olivier Glehen, Pierre Philouze, François Tronc, Thomas Walter, Benoît You, Gilles Freyer
Publikováno v:
Cancers
Cancers, Vol 14, Iss 29, p 29 (2022)
Cancers, Vol 14, Iss 29, p 29 (2022)
Simple Summary This article presents the protective measures put in place at the “Institut de Cancérologie des Hospices de Lyon” (IC-HCL) during the first wave of the COVID-19 pandemic in France (spring 2020) and how they impacted IC-HCL clinica
Autor:
V. Corset, Sandrine Paindavoine, David Meyronet, Marie Blonski, Emilie Lavergne, Sylvie Chabaud, Valéry Attignon, Jean-Yves Blay, Luc Taillandier, Sylvie Lantuejoul, François Ducray, Olivier Tredan, Didier Frappaz, Emilie Sohier, Christian Baudet, V. Agrapart, David Pérol, Christine Rodriguez, Daniel Pissaloux, Alice Bonneville-Levard, Qing Wang, Isabelle Treilleux, Alain Viari, Laure Thomas-Maisonneuve, Jérôme Honnorat, Stéphanie Cartalat
Publikováno v:
Medical Oncology
Medical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩
Medical Oncology, 2021, 39 (1), pp.4. ⟨10.1007/s12032-021-01536-4⟩
International audience; Immunohistochemistry and recent molecular technologies progressively guided access to personalized anti-tumoral therapies. We explored the feasibility, efficacy, and the impact of molecular profiling in patients with advanced
Autor:
Grigorios, Gkasdaris, Alexandre, Vasiljevic, Stéphanie, Cartalat, Isabelle, Pelissou-Guyotat, Jacques, Guyotat, Chloé, Dumot, Thiebaud, Picart, Moncef, Berhouma
Publikováno v:
Clinical Neurology and Neurosurgery. 223:107498
Meningiomas are the most common benign intracranial tumors. They are generally asymptomatic, and discovered incidentally during cerebral imaging. The vast majority of meningiomas are solid, highly cellular and well-vascularized neoplasms. However, in
Autor:
Delphine Maucort-Boulch, Amelie Darlix, Roxana Ameli, Olivier Chinot, Caroline Dehais, David Meyronet, Laure Thomas-Maisonneuve, Alice Bonneville-Levard, Jérôme Honnorat, François Gueyffier, Marc Sanson, François Ducray, Emeline Tabouret, Laurent Remontet, Maxime Fontanilles, Stéphanie Cartalat, Romain Rivoirard
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.2007-2007. ⟨10.1200/JCO.2021.39.15_suppl.2007⟩
Journal of Clinical Oncology, 2021, 39 (15_suppl), pp.2007-2007. ⟨10.1200/JCO.2021.39.15_suppl.2007⟩
2007 Background: There is a need to develop new treatments in IDH-mutant high-grade gliomas recurring after radiotherapy and chemotherapy. Based on preclinical studies showing that IDH-mutant tumors could be vulnerable to PARP inhibition we launched
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1525ddeff73faaa6152f9730c47e4e41
https://hal.science/hal-03603885
https://hal.science/hal-03603885
Autor:
Anderson Loundou, Luc Taillandier, Marc Sanson, Olivier Chinot, Jean-Yves Delattre, Dominique Figarella-Branger, Rémy Guillevin, Michel Fabbro, Maryline Barrie, Khê Hoang-Xuan, Didier Autran, Karima Mokhtari, François Ducray, Christine Kerr, Stéphanie Cartalat-Carel, Emeline Tabouret
Publikováno v:
Oncologist
Oncologist, 2021, ⟨10.1002/onco.13765⟩
Oncologist, AlphaMed Press, 2021, ⟨10.1002/onco.13765⟩
Oncologist, 2021, ⟨10.1002/onco.13765⟩
Oncologist, AlphaMed Press, 2021, ⟨10.1002/onco.13765⟩
Lessons Learned Background The optimal treatment for unresectable large anaplastic gliomas remains debated. Methods Adult patients with histologically proven unresectable anaplastic oligodendroglioma or mixed gliomas (World Health Organization [WHO]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::585fc36eac83f02e2d2973e8fd619374
https://hal.science/hal-03253040
https://hal.science/hal-03253040
Autor:
Stéphanie Cartalat, Cristina Izquierdo, Jacques Guyotat, Jordi Bruna, Delphine Poncet, François Ducray, Tanguy Fenouil, Emmanuel Jouanneau, Yves Berthezène, Alexandre Vasiljevic, David Meyronet, Bastien Joubert, Jérôme Honnorat, Marc Barritault
Publikováno v:
Neurosurgery. 85:E448-E456
Adult IDH-wildtype astrocytomas with TERT promoter mutations (TERTp) are associated with a poor prognosis.To analyze the radiological presentation and natural history of adult IDH-wildtype astrocytomas with TERTp.We retrospectively reviewed the chara